What is Leqembi? The FDA Approved a Milestone Alzheimer's Drug – SheKnows

Leqembi is an antibody that reduces the number of beta-amyloid plaques in people with early-stage Alzheimer's. The drug helps slow down memory loss.

Related Keywords

Thomas Wisniewski ,Teresa Buracchio ,Alzheimer Disease Research Center ,Office Of Neuroscience ,Flow Advisory Council ,Langone Health ,Disease Research Center ,Drug Evaluation ,Kellyann Niotis ,